Investigators

Prof. Jochen Prehn
Director of Centre for Systems Medicine
Head of Department of Physiology and Medical Physics
Team Members and Research and Mentoring and Supervision

Dr. Annette Byrne
Lecturer
Team Members and Research 

Dr. Markus Rehm
Visiting Professor
Team Members and Research 

Dr. Heinrich Huber
Adjunct Senior Lecturer
Team Members and Research 

Dr. Brona Murphy

Lecturer
Team Members and Research  

Dr. David Hughes
Senior Research Fellow
Research  

Prof. Elaine Kay
Consultant Histopathologist at Beaumont Hospital

Dr. Brain Hennessy
Consultant Medical Oncologist at Beaumont Hospital

Dr. Maria M Byrne
Consultant Endocrinologist/Diabetologist, Senior Lecturer at Mater Misericordiae University Hospital

Dr. Amanda Tivnan
Research Fellowship by the Irish Cancer Society

Dr. Tríona Ní Chonghaile
Research Lecturer Team Members, Research and News

 

 

 

 

Recent Posts

RCSI to train new generation of researchers as part of another international study to tackle most common brain diseases

More great news for the Department

PurinesDX_logo_PNG_Black

 

Thursday, 9th November 2017:  RCSI  is leading an international team of scientists on a major research study that aims to train the next generation of specialists in purinergic signalling during brain diseases. The project (“PurinesDX”) aims to establish the potential of newly developed devices to better diagnose and treat patients. Brain disorders affect 180 million people and their families in Europe alone.  PurinesDX has received funding of over €3.5 million from the European Commission’s Horizon 2020 Research and Innovation Framework Programme.

The research project brings together global leaders in translational research in purinergic signalling, Europe’s leading clinical specialists in a broad range of brain diseases, and industrial partners specializing in drug and biomarker development from six different European countries. The main aim of PurinesDX is to train an urgently needed new generation of highly skilled, innovative, creative and entrepreneurial early stage researchers and to tackle brain disorders.

The project is led by Dr Tobias Engel, RCSI Department of Physiology and Medical Physics. “Despite diversity in symptomatology and etiology of brain diseases, it is becoming increasingly clear that neuroinflammation-induced hyperexcitability plays a key role in common mechanisms underlying both primary disorders of the brain and their shared co-morbidities. PurinesDX has identified the ATP-gated purinergic P2X7 receptor as the ideal target. By sharing unique genetic tools, newly developed diagnostic devices and novel, selective and brain-stable P2X7 antagonists, the synergism facilitated within PurinesDX will determine the therapeutic potential of targeting P2X7 in a wide array of the most common brain diseases and provide, at the same time, a high level training in state-of-the-art neuroscience for early stage researchers.” Dr Engel said.

purinesDX

 

PurinesDX includes major academic and industry researchers from across Europe, including collaborators in Ireland (Longboat Clinical); Germany (University Ludwig Maximilans; Max Planck Institute of Psychiatry; Dr Seibt Genomics; Epilepsy Centre Frankfurt Rhein-Main; Affectis Pharmaceuticals AG); Hungary (Institute of Experimental Medicine, Hungarian Academy of Sciences; Bio Talentum; Semmelweis University); Belgium (Janssen Pharmaceutica NV); Spain (University Complutense Madrid; CIBERNED, CIEN, Foundation Teofilo Hernando; Ramon y Cajal Hospital); and the UK (Sarissa Biomedical).

The four-year project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766124.

 

 

 

 

 

 

 

 

 

  1. Brain Tumor Ireland Biobank Progress Meeting was held at RCSI on Wednesday 26th Oct 2017 Comments Off on Brain Tumor Ireland Biobank Progress Meeting was held at RCSI on Wednesday 26th Oct 2017
  2. RCSI wins prestigious tripartite €5.1 million award as part of Global Project to Tackle Colorectal Cancer Comments Off on RCSI wins prestigious tripartite €5.1 million award as part of Global Project to Tackle Colorectal Cancer
  3. Congrats to Dr. Marc Sturrock on his success in obtaining a grant from the Royal Irish Academy Comments Off on Congrats to Dr. Marc Sturrock on his success in obtaining a grant from the Royal Irish Academy
  4. RCSI/CSM to lead major international study to improve treatment outcomes for brain cancer patients Comments Off on RCSI/CSM to lead major international study to improve treatment outcomes for brain cancer patients
  5. Applications open for TY Mini-Science 5th-7th of Feb 2018 Comments Off on Applications open for TY Mini-Science 5th-7th of Feb 2018
  6. European Training Network 15 New PhD Student Positions -Application closing date: Friday 10th Nov 2017 Comments Off on European Training Network 15 New PhD Student Positions -Application closing date: Friday 10th Nov 2017
  7. Great news for our department and centre: SFI announced it will fund a new Research Centre based at RCSI called FutureNeuro Comments Off on Great news for our department and centre: SFI announced it will fund a new Research Centre based at RCSI called FutureNeuro
  8. SBI-EMBL Scientific Meeting Interpreting Genomes & Genome Functions Science Meeting | UCD Conway Institute | 11-12 September 2017 Comments Off on SBI-EMBL Scientific Meeting Interpreting Genomes & Genome Functions Science Meeting | UCD Conway Institute | 11-12 September 2017
  9. European Training Network – 14 PhD positions Comments Off on European Training Network – 14 PhD positions